PharmGKB Blog
Thursday, September 26, 2019

CYP2D6 Gene Review by PharmVar published in CPT

›
The Pharmacogene Variation ( PharmVar ) Consortium   just published the inaugural article of a gene-centered series of review papers in   C...
Friday, September 20, 2019

ACLA writes to the FDA about PGx testing

›
The American Clinical Laboratory Association (ACLA) has written a letter to the US Food and Drug Administration (FDA) regarding the FDA’s re...
Tuesday, September 10, 2019

Michelle Whirl-Carrillo -- Director of the PharmGKB!

›
We are happy to announce that Dr. Michelle Whirl-Carrillo has agreed to take on the position of Director of PharmGKB. Michelle has worked wi...
Wednesday, August 14, 2019

Pilot study from Genomics England to report on DPYD variants

›
A pilot study from Genomics England  is now reporting back DPYD variants in cancer patients as part of the 100,000 Genomes Project. The DP...
Monday, July 29, 2019

PharmCAT article published in Clinical Pharmacology & Therapeutics

›
The article describing the Pharmacogenomics Clinical Annotation Tool ( PharmCAT )  and a pilot validation using GeT-RM samples  was recentl...
Wednesday, July 10, 2019

CYP2C9, CYP2C19, and CYP2D6 core alleles

›
We recently  blogged  about the use of PharmVar core alleles as the basis for the PharmGKB/CPIC  CYP2D6 ,  CYP2C19 , and  CYP2C9  allele def...
Tuesday, July 2, 2019

CPIC to issue guidance on non-actionable pharmacogenes

›
The Clinical Pharmacogenetics Implementation Consortium (CPIC)  hopes to provide more guidance in the future about gene...
‹
›
Home
View web version

Contributors

  • Caroline Thorn, Curator
  • Katrin Sangkuhl
  • Li Gong
  • Mark Woon
  • Mark Woon
  • Michelle Whirl-Carrillo, Director and Co-PI
  • Ryan Whaley, Technical Lead
  • Teri Klein, Co-PI PharmGKB, CPIC, PharmCAT & ClinGen
Powered by Blogger.